4-188142282-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_178556.5(TRIML1):āc.535G>Cā(p.Val179Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000496 in 1,612,058 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_178556.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRIML1 | NM_178556.5 | c.535G>C | p.Val179Leu | missense_variant | 3/6 | ENST00000332517.4 | NP_848651.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIML1 | ENST00000332517.4 | c.535G>C | p.Val179Leu | missense_variant | 3/6 | 1 | NM_178556.5 | ENSP00000327738 | P1 | |
ENST00000501322.2 | n.452+646C>G | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000464 AC: 7AN: 150738Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000439 AC: 11AN: 250426Hom.: 0 AF XY: 0.0000517 AC XY: 7AN XY: 135484
GnomAD4 exome AF: 0.0000500 AC: 73AN: 1461320Hom.: 0 Cov.: 33 AF XY: 0.0000509 AC XY: 37AN XY: 726948
GnomAD4 genome AF: 0.0000464 AC: 7AN: 150738Hom.: 0 Cov.: 30 AF XY: 0.0000272 AC XY: 2AN XY: 73512
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2023 | The c.535G>C (p.V179L) alteration is located in exon 3 (coding exon 3) of the TRIML1 gene. This alteration results from a G to C substitution at nucleotide position 535, causing the valine (V) at amino acid position 179 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at